NDLI: Retail sales of inhalation devices in European countries: so much for a global policy.

Content Provider	World Health Organization (WHO)-Global Index Medicus
Author	Lavorini, F. Corrigan, C. J. Barnes, P. J. Dekhuijzen, P. R. N. Levy, M. L. Pedersen, S. Roche, N. Vincken, W. Crompton, G. K.
Spatial Coverage	Europe
Description	Country affiliation: Italy Author Affiliation: Lavorini F ( Department of Internal Medicine, Section of Immunoallergology, Respiratory Diseases and Cell Therapy, University of Florence, Florence, Italy. federico.lavorini@unifi.it)
Abstract	OBJECTIVE: To evaluate the retail sales of pressurised metered-dose inhalers (pMDIs), dry-powder inhalers (DPIs) and liquids for nebulisation in 16 European countries. METHODS: Retail sales data relating to pMDIs, DPIs and liquids for nebulisation delivering short- and long-acting bronchodilators, corticosteroids and combinations between 2002 and 2008 were obtained from the IMS sales database. The IMS database ensured that wholesalers' stock sales accurately matched that of retail pharmacies and included purchases by panel pharmacies directly from pharmaceutical manufacturers, specialist wholesalers and distribution cooperatives. RESULTS: Mean inhaler retail sales (expressed as percentages of total sales) were 47.5% for pMDIs, 39.5% for DPIs and 13% for nebulisers. The distribution of inhaler sales differed significantly between the countries with pMDI sales greatest in the United Kingdom and Hungary compared to other countries, where DPI sales prevailed. Sales of nebulisation liquids were high in Italy. The pMDI was the most frequently prescribed inhaler for bronchodilators. In contrast, retail sales of DPIs were similar to those of pMDIs for inhaled corticosteroids, and higher in the case of inhalers with combined long-acting ß(2)-agonist and corticosteroid. CONCLUSION: We found a high degree of variability in inhaler prescription between European countries. Differing health policies, costs, health insurance issues, pharmaceutical/commercial aspects and prescribers' and patients' preferences may explain this variation. We suggest a need for more uniform, outcome-led inhaler prescribing practice across Europe to improve the efficacy and cost effectiveness of the treatment of obstructive airways diseases.
File Format	HTM / HTML
ISSN	09546111
Issue Number	7
Volume Number	105
e-ISSN	15323064
Journal	Respiratory Medicine
Language	English
Publisher	Elsevier
Publisher Date	2011-07-01
Publisher Place	Great Britain (UK)
Access Restriction	One Nation One Subscription (ONOS)
Subject Keyword	Discipline Pulmonary Medicine Adrenal Cortex Hormones Administration & Dosage Asthma Drug Therapy Bronchodilator Agents Nebulizers And Vaporizers Supply & Distribution Physician's Practice Patterns Statistics & Numerical Data Pulmonary Disease, Chronic Obstructive Dry Powder Inhalers Europe Female Health Policy Humans Male Metered Dose Inhalers Economics Journal Article
Content Type	Text
Resource Type	Article
Subject	Pulmonary and Respiratory Medicine

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Asthma medication delivery: mists and myths.

Nebulized Therapies in COPD: Past, Present, and the Future.

Plume Characteristics of Two HFA-Driven Inhaled Corticosteroid/Long-Acting Beta2-Agonist Combination Pressurized Metered-Dose Inhalers.

Prescription of inhalers in asthma and COPD: towards a rational, rapid and effective approach.

The ADMIT series--issues in inhalation therapy. 5) Inhaler selection in children with asthma.

Knowledge of and technique for using inhalation devices among asthma patients and COPD patients

Inhaler devices - from theory to practice.

In reference to 'Nebulized bronchodilators instead of metered-dose inhalers for obstructive pulmonary symptoms'.

Inhaler device selection: special considerations in elderly patients with chronic obstructive pulmonary disease.

Retail sales of inhalation devices in European countries: so much for a global policy.

Similar Documents

Asthma medication delivery: mists and myths.

Nebulized Therapies in COPD: Past, Present, and the Future.

Plume Characteristics of Two HFA-Driven Inhaled Corticosteroid/Long-Acting Beta2-Agonist Combination Pressurized Metered-Dose Inhalers.

Prescription of inhalers in asthma and COPD: towards a rational, rapid and effective approach.

The ADMIT series--issues in inhalation therapy. 5) Inhaler selection in children with asthma.

Knowledge of and technique for using inhalation devices among asthma patients and COPD patients

Inhaler devices - from theory to practice.

In reference to 'Nebulized bronchodilators instead of metered-dose inhalers for obstructive pulmonary symptoms'.

Inhaler device selection: special considerations in elderly patients with chronic obstructive pulmonary disease.

Retail sales of inhalation devices in European countries: so much for a global policy.